Therapeutic BCL11A enhancer gene editing to induce fetal hemoglobin in β-hemoglobinopathy patients
$886,788OT2FY2021HLNIH
Boston Children'S Hospital, Boston MA
Investigators
Linked publications, trials & patents
Abstract
No abstract provided
View original record on NIH RePORTER →